Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Medical and Pediatric Oncology|April 1, 1995
Reversible thrombocytopenia with levamisoleE W Winquist, N J LassamCancer Research|May 15, 1993
Overexpression of p53 is a late event in the development of malignant melanomaN J Lassam, L From, H J KahnCell|November 1, 1979
Tumor antigens of human Ad5 in transformed cells and in cells infected with transformation-defective host-range mutantsN J Lassam, S T Bayley, F L GrahamGenes, Chromosomes & Cancer|March 17, 2000
Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutationsG Lal, L Liu, D Hogg, et al.Oncogene|June 1, 1994
MLK-3: identification of a widely-expressed protein kinase bearing an SH3 domain and a leucine zipper-basic region domainY L Ing, I W Leung, H H Heng, et al.Journal of Cutaneous Medicine and Surgery|April 29, 1998
Role of the cyclin-dependent kinase inhibitor CDKN2A in familial melanomaD Hogg, H Brill, L Liu, et al.Melanoma Research|October 1, 1994
Protein kinases in normal and transformed melanocytesR Y Quong, S T Bickford, Y L Ing, et al.Oncogene|July 20, 1995
Germline p16INK4A mutation and protein dysfunction in a family with inherited melanomaL Liu, N J Lassam, J M Slingerland, et al.Journal of Pediatric Hematology/Oncology|October 19, 2000
Concurrent acute lymphoblastic leukemia and juvenile pilocytic astrocytoma in a pediatric patientA L Kim, C V Fernandez, W L Greer, et al.Human Genetics|June 1, 1997
Fine mapping of the MLK-3 gene within 11q13 and its exclusion as the MEN1 susceptibility geneN J Lassam, Z Lin, M G Shennan, et al.Pageof 2